Dr. Erwin Van MeirProfessor
Associate Director for Shared Resources, O’Neal Comprehensive Cancer Center at UAB

Areas of Interest
molecular neuro-oncology, cancer cell signaling, drug discovery

Google Scholar

Lab Website

Dr. Erwin Van Meir is a professor in the UAB Department of Neurosurgery. His research interest lies in understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics that will improve patient survival. Van Meir's research examines how genetic alterations and hypoxia induce changes in cell biology that promote tumor formation with particular emphasis on heterotypic cell-cell signaling, including tumor angiogenesis. Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic molecules and is currently developing novel small molecule inhibitors of the hypoxia-inducible factor pathway. His research aims to translate these novel agents to testing in clinical trials with the hope to develop novel medicines for cancer treatment. The principal modeling systems he uses in his lab are malignant brain (glioblastoma and medulloblastoma) and eye (metastatic uveal melanoma) cancers, although the experimental therapeutics he develops are applicable to the cure of many solid malignancies.

Education

Postgraduate Training

Ludwig Institute for Cancer Research, San Diego, California
Postdoctoral Scientist

Doctoral Degree

University of Lausanne, Switzerland
Ph.D., Molecular Virology

Educational Degree

University of Fribourg, Switzerland

Bachelor's Degree

University of Fribourg, Switzerland
B.S., Biology

Contact

Campus Address
WTI 520E

Phone
(205) 996-2098

Email
egvanmeir@uabmc.edu